Document is current
Any future updates will be listed below
-
Authors
Paul, Nina B.
Strauss, Gregory P.
Gates-Woodyatt, Jessica J.
Barchard, Kimberly A.
Allen, Daniel N. https://orcid.org/0000-0003-4868-2242
-
Funding
Funding for this research was provided by:
National Institute of Mental Health (R21- MH112925, K23-MH092530)
- License Information
-
More Information
Article History
Received: 11 August 2021
Accepted: 14 October 2022
First Online: 12 January 2023
Declarations
:
: Gregory Strauss is one of the original developers of the Brief Negative Symptom Scale (BNSS) and receives royalties and consultation fees from ProPhase LLC in connection with commercial use of the BNSS and other professional activities; these fees are donated to the Brain and Behavior Research Foundation. Dr. Strauss has received honoraria and travel support from ProPhase LLC for training pharmaceutical company raters on the BNSS. In the past two years, Dr. Strauss has consulted for and/or been on the speaker bureau for Minerva Neurosciences, Acadia, and Lundbeck pharmaceutical companies. Nina Paul, Jessica Woodyatt, Kimberly Barchard, and Daniel Allen have no relevant disclosures to report.
: Data analyzed for this study was deidentified and archival so was exempt according to UNLV Institutional Review Board for Protection of Human Subjects.
: Data was deidentified and archival.
: Not applicable.
